世界の腎臓シスチン症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Nephropathic Cystinosis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4563 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、腎臓シスチン症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（システイン枯渇療法、対症療法、腎移植）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・腎臓シスチン症治療の市場動向 ・企業の競争状況、市場シェア ・腎臓シスチン症治療の種類別市場規模と予測2016-2027（システイン枯渇療法、対症療法、腎移植） ・腎臓シスチン症治療の用途別市場規模と予測2016-2027（病院、クリニック、外来手術センター、その他） ・腎臓シスチン症治療の北米市場規模2016-2027（アメリカ、カナダ） ・腎臓シスチン症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・腎臓シスチン症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腎臓シスチン症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・腎臓シスチン症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Horizon Therapeutics、Mylan、Chiesi Farmaceutici S.p.A.、Recordati Rare Diseases、AVROBIO, Inc.、Leadiant Biosciences, Inc.、Eloxx Pharmaceuticals） ・結論

Market Analysis and Insights: Global Nephropathic Cystinosis Treatment Market
The global Nephropathic Cystinosis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nephropathic Cystinosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nephropathic Cystinosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nephropathic Cystinosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nephropathic Cystinosis Treatment market.

Global Nephropathic Cystinosis Treatment Scope and Market Size
Nephropathic Cystinosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nephropathic Cystinosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cysteine Depleting Therapy
Symptomatic Therapy
Renal Transplantation

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Horizon Therapeutics
Mylan
Chiesi Farmaceutici S.p.A.
Recordati Rare Diseases
AVROBIO, Inc.
Leadiant Biosciences, Inc.
Eloxx Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nephropathic Cystinosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cysteine Depleting Therapy
1.2.3 Symptomatic Therapy
1.2.4 Renal Transplantation
1.3 Market by Application
1.3.1 Global Nephropathic Cystinosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Nephropathic Cystinosis Treatment Market Perspective (2016-2027)
2.2 Nephropathic Cystinosis Treatment Growth Trends by Regions
2.2.1 Nephropathic Cystinosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nephropathic Cystinosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Nephropathic Cystinosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Nephropathic Cystinosis Treatment Industry Dynamic
2.3.1 Nephropathic Cystinosis Treatment Market Trends
2.3.2 Nephropathic Cystinosis Treatment Market Drivers
2.3.3 Nephropathic Cystinosis Treatment Market Challenges
2.3.4 Nephropathic Cystinosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Nephropathic Cystinosis Treatment Players by Revenue
3.1.1 Global Top Nephropathic Cystinosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Nephropathic Cystinosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Nephropathic Cystinosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nephropathic Cystinosis Treatment Revenue
3.4 Global Nephropathic Cystinosis Treatment Market Concentration Ratio
3.4.1 Global Nephropathic Cystinosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nephropathic Cystinosis Treatment Revenue in 2020
3.5 Nephropathic Cystinosis Treatment Key Players Head office and Area Served
3.6 Key Players Nephropathic Cystinosis Treatment Product Solution and Service
3.7 Date of Enter into Nephropathic Cystinosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Nephropathic Cystinosis Treatment Breakdown Data by Type
4.1 Global Nephropathic Cystinosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Nephropathic Cystinosis Treatment Forecasted Market Size by Type (2022-2027)

5 Nephropathic Cystinosis Treatment Breakdown Data by Application
5.1 Global Nephropathic Cystinosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Nephropathic Cystinosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Nephropathic Cystinosis Treatment Market Size (2016-2027)
6.2 North America Nephropathic Cystinosis Treatment Market Size by Type
6.2.1 North America Nephropathic Cystinosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Nephropathic Cystinosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Nephropathic Cystinosis Treatment Market Size by Type (2016-2027)
6.3 North America Nephropathic Cystinosis Treatment Market Size by Application
6.3.1 North America Nephropathic Cystinosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Nephropathic Cystinosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Nephropathic Cystinosis Treatment Market Size by Application (2016-2027)
6.4 North America Nephropathic Cystinosis Treatment Market Size by Country
6.4.1 North America Nephropathic Cystinosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Nephropathic Cystinosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Nephropathic Cystinosis Treatment Market Size (2016-2027)
7.2 Europe Nephropathic Cystinosis Treatment Market Size by Type
7.2.1 Europe Nephropathic Cystinosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Nephropathic Cystinosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Nephropathic Cystinosis Treatment Market Size by Type (2016-2027)
7.3 Europe Nephropathic Cystinosis Treatment Market Size by Application
7.3.1 Europe Nephropathic Cystinosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Nephropathic Cystinosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Nephropathic Cystinosis Treatment Market Size by Application (2016-2027)
7.4 Europe Nephropathic Cystinosis Treatment Market Size by Country
7.4.1 Europe Nephropathic Cystinosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Nephropathic Cystinosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Nephropathic Cystinosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Type
8.2.1 Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Application
8.3.1 Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Region
8.4.1 Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Nephropathic Cystinosis Treatment Market Size (2016-2027)
9.2 Latin America Nephropathic Cystinosis Treatment Market Size by Type
9.2.1 Latin America Nephropathic Cystinosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Nephropathic Cystinosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Nephropathic Cystinosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Nephropathic Cystinosis Treatment Market Size by Application
9.3.1 Latin America Nephropathic Cystinosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Nephropathic Cystinosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Nephropathic Cystinosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Nephropathic Cystinosis Treatment Market Size by Country
9.4.1 Latin America Nephropathic Cystinosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Nephropathic Cystinosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Nephropathic Cystinosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Type
10.2.1 Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Application
10.3.1 Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Country
10.4.1 Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Horizon Therapeutics
11.1.1 Horizon Therapeutics Company Details
11.1.2 Horizon Therapeutics Business Overview
11.1.3 Horizon Therapeutics Nephropathic Cystinosis Treatment Introduction
11.1.4 Horizon Therapeutics Revenue in Nephropathic Cystinosis Treatment Business (2016-2021)
11.1.5 Horizon Therapeutics Recent Development
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Mylan Business Overview
11.2.3 Mylan Nephropathic Cystinosis Treatment Introduction
11.2.4 Mylan Revenue in Nephropathic Cystinosis Treatment Business (2016-2021)
11.2.5 Mylan Recent Development
11.3 Chiesi Farmaceutici S.p.A.
11.3.1 Chiesi Farmaceutici S.p.A. Company Details
11.3.2 Chiesi Farmaceutici S.p.A. Business Overview
11.3.3 Chiesi Farmaceutici S.p.A. Nephropathic Cystinosis Treatment Introduction
11.3.4 Chiesi Farmaceutici S.p.A. Revenue in Nephropathic Cystinosis Treatment Business (2016-2021)
11.3.5 Chiesi Farmaceutici S.p.A. Recent Development
11.4 Recordati Rare Diseases
11.4.1 Recordati Rare Diseases Company Details
11.4.2 Recordati Rare Diseases Business Overview
11.4.3 Recordati Rare Diseases Nephropathic Cystinosis Treatment Introduction
11.4.4 Recordati Rare Diseases Revenue in Nephropathic Cystinosis Treatment Business (2016-2021)
11.4.5 Recordati Rare Diseases Recent Development
11.5 AVROBIO, Inc.
11.5.1 AVROBIO, Inc. Company Details
11.5.2 AVROBIO, Inc. Business Overview
11.5.3 AVROBIO, Inc. Nephropathic Cystinosis Treatment Introduction
11.5.4 AVROBIO, Inc. Revenue in Nephropathic Cystinosis Treatment Business (2016-2021)
11.5.5 AVROBIO, Inc. Recent Development
11.6 Leadiant Biosciences, Inc.
11.6.1 Leadiant Biosciences, Inc. Company Details
11.6.2 Leadiant Biosciences, Inc. Business Overview
11.6.3 Leadiant Biosciences, Inc. Nephropathic Cystinosis Treatment Introduction
11.6.4 Leadiant Biosciences, Inc. Revenue in Nephropathic Cystinosis Treatment Business (2016-2021)
11.6.5 Leadiant Biosciences, Inc. Recent Development
11.7 Eloxx Pharmaceuticals
11.7.1 Eloxx Pharmaceuticals Company Details
11.7.2 Eloxx Pharmaceuticals Business Overview
11.7.3 Eloxx Pharmaceuticals Nephropathic Cystinosis Treatment Introduction
11.7.4 Eloxx Pharmaceuticals Revenue in Nephropathic Cystinosis Treatment Business (2016-2021)
11.7.5 Eloxx Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Nephropathic Cystinosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cysteine Depleting Therapy
Table 3. Key Players of Symptomatic Therapy
Table 4. Key Players of Renal Transplantation
Table 5. Global Nephropathic Cystinosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Nephropathic Cystinosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Nephropathic Cystinosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Nephropathic Cystinosis Treatment Market Share by Regions (2016-2021)
Table 9. Global Nephropathic Cystinosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Nephropathic Cystinosis Treatment Market Share by Regions (2022-2027)
Table 11. Nephropathic Cystinosis Treatment Market Trends
Table 12. Nephropathic Cystinosis Treatment Market Drivers
Table 13. Nephropathic Cystinosis Treatment Market Challenges
Table 14. Nephropathic Cystinosis Treatment Market Restraints
Table 15. Global Nephropathic Cystinosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Nephropathic Cystinosis Treatment Market Share by Players (2016-2021)
Table 17. Global Top Nephropathic Cystinosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nephropathic Cystinosis Treatment as of 2020)
Table 18. Ranking of Global Top Nephropathic Cystinosis Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Nephropathic Cystinosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Nephropathic Cystinosis Treatment Product Solution and Service
Table 22. Date of Enter into Nephropathic Cystinosis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nephropathic Cystinosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Nephropathic Cystinosis Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Nephropathic Cystinosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Nephropathic Cystinosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Nephropathic Cystinosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Nephropathic Cystinosis Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Nephropathic Cystinosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Nephropathic Cystinosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Nephropathic Cystinosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Nephropathic Cystinosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Nephropathic Cystinosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Nephropathic Cystinosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Nephropathic Cystinosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Nephropathic Cystinosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Nephropathic Cystinosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Nephropathic Cystinosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Nephropathic Cystinosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Nephropathic Cystinosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Nephropathic Cystinosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Nephropathic Cystinosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Nephropathic Cystinosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Nephropathic Cystinosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Nephropathic Cystinosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Nephropathic Cystinosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Nephropathic Cystinosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Nephropathic Cystinosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Nephropathic Cystinosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Nephropathic Cystinosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Horizon Therapeutics Company Details
Table 63. Horizon Therapeutics Business Overview
Table 64. Horizon Therapeutics Nephropathic Cystinosis Treatment Product
Table 65. Horizon Therapeutics Revenue in Nephropathic Cystinosis Treatment Business (2016-2021) & (US$ Million)
Table 66. Horizon Therapeutics Recent Development
Table 67. Mylan Company Details
Table 68. Mylan Business Overview
Table 69. Mylan Nephropathic Cystinosis Treatment Product
Table 70. Mylan Revenue in Nephropathic Cystinosis Treatment Business (2016-2021) & (US$ Million)
Table 71. Mylan Recent Development
Table 72. Chiesi Farmaceutici S.p.A. Company Details
Table 73. Chiesi Farmaceutici S.p.A. Business Overview
Table 74. Chiesi Farmaceutici S.p.A. Nephropathic Cystinosis Treatment Product
Table 75. Chiesi Farmaceutici S.p.A. Revenue in Nephropathic Cystinosis Treatment Business (2016-2021) & (US$ Million)
Table 76. Chiesi Farmaceutici S.p.A. Recent Development
Table 77. Recordati Rare Diseases Company Details
Table 78. Recordati Rare Diseases Business Overview
Table 79. Recordati Rare Diseases Nephropathic Cystinosis Treatment Product
Table 80. Recordati Rare Diseases Revenue in Nephropathic Cystinosis Treatment Business (2016-2021) & (US$ Million)
Table 81. Recordati Rare Diseases Recent Development
Table 82. AVROBIO, Inc. Company Details
Table 83. AVROBIO, Inc. Business Overview
Table 84. AVROBIO, Inc. Nephropathic Cystinosis Treatment Product
Table 85. AVROBIO, Inc. Revenue in Nephropathic Cystinosis Treatment Business (2016-2021) & (US$ Million)
Table 86. AVROBIO, Inc. Recent Development
Table 87. Leadiant Biosciences, Inc. Company Details
Table 88. Leadiant Biosciences, Inc. Business Overview
Table 89. Leadiant Biosciences, Inc. Nephropathic Cystinosis Treatment Product
Table 90. Leadiant Biosciences, Inc. Revenue in Nephropathic Cystinosis Treatment Business (2016-2021) & (US$ Million)
Table 91. Leadiant Biosciences, Inc. Recent Development
Table 92. Eloxx Pharmaceuticals Company Details
Table 93. Eloxx Pharmaceuticals Business Overview
Table 94. Eloxx Pharmaceuticals Nephropathic Cystinosis Treatment Product
Table 95. Eloxx Pharmaceuticals Revenue in Nephropathic Cystinosis Treatment Business (2016-2021) & (US$ Million)
Table 96. Eloxx Pharmaceuticals Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nephropathic Cystinosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Cysteine Depleting Therapy Features
Figure 3. Symptomatic Therapy Features
Figure 4. Renal Transplantation Features
Figure 5. Global Nephropathic Cystinosis Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Nephropathic Cystinosis Treatment Report Years Considered
Figure 11. Global Nephropathic Cystinosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Nephropathic Cystinosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Nephropathic Cystinosis Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Nephropathic Cystinosis Treatment Market Share by Regions (2022-2027)
Figure 15. Global Nephropathic Cystinosis Treatment Market Share by Players in 2020
Figure 16. Global Top Nephropathic Cystinosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nephropathic Cystinosis Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Nephropathic Cystinosis Treatment Revenue in 2020
Figure 18. Global Nephropathic Cystinosis Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Nephropathic Cystinosis Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Nephropathic Cystinosis Treatment Market Share by Type (2016-2027)
Figure 22. North America Nephropathic Cystinosis Treatment Market Share by Application (2016-2027)
Figure 23. North America Nephropathic Cystinosis Treatment Market Share by Country (2016-2027)
Figure 24. United States Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Nephropathic Cystinosis Treatment Market Share by Type (2016-2027)
Figure 28. Europe Nephropathic Cystinosis Treatment Market Share by Application (2016-2027)
Figure 29. Europe Nephropathic Cystinosis Treatment Market Share by Country (2016-2027)
Figure 30. Germany Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Nephropathic Cystinosis Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Nephropathic Cystinosis Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Nephropathic Cystinosis Treatment Market Share by Region (2016-2027)
Figure 40. China Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Nephropathic Cystinosis Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Nephropathic Cystinosis Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Nephropathic Cystinosis Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Nephropathic Cystinosis Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Nephropathic Cystinosis Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Nephropathic Cystinosis Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Nephropathic Cystinosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Horizon Therapeutics Revenue Growth Rate in Nephropathic Cystinosis Treatment Business (2016-2021)
Figure 60. Mylan Revenue Growth Rate in Nephropathic Cystinosis Treatment Business (2016-2021)
Figure 61. Chiesi Farmaceutici S.p.A. Revenue Growth Rate in Nephropathic Cystinosis Treatment Business (2016-2021)
Figure 62. Recordati Rare Diseases Revenue Growth Rate in Nephropathic Cystinosis Treatment Business (2016-2021)
Figure 63. AVROBIO, Inc. Revenue Growth Rate in Nephropathic Cystinosis Treatment Business (2016-2021)
Figure 64. Leadiant Biosciences, Inc. Revenue Growth Rate in Nephropathic Cystinosis Treatment Business (2016-2021)
Figure 65. Eloxx Pharmaceuticals Revenue Growth Rate in Nephropathic Cystinosis Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---